glp 1 agonists and sglt2 inhibitors SGLT-2 GLP-1 Agonists: First-Line Therapy for Diabetes With Established Cardiovascular Disease Role of GLP-1 Agonists &
Description
Systematic Reviews and Meta-analyses One collaborative meta-analysis that synthesized the cardiovascular outcomes reported the results from four studies and 45,568 patients on the add-on therapy modalities [20]

Physician Shift Toward Once-Weekly And Dual-Incretin Therapies Brazilian and Mexican endocrinologists report 30%-40% higher 12-month persistence for once-weekly semaglutide or dulaglutide compared with daily liraglutide

SOURCE: Gala Source: Gala

For women in perimenopause and menopause, dosing decisions should follow a structured evaluation

Tips to Save on GLP-1 Drugs When You Dont Have Insurance The retail price of GLP-1 medications can feel like a dead end when insurance wont help

Mansur RB, Delgado-Peraza F, Subramaniapillai M, Lee Y, Iacobucci M, Nasri F, et al
